U D Nagaraj1, J L Peiro2, K S Bierbrauer3, B M Kline-Fath4. 1. From the Departments of Radiology and Medical Imaging (U.D.N., B.M.K.-F) University of Cincinnati College of Medicine (U.D.N., J.L.P., K.S.B., B.M.K.-F), Cincinnati, Ohio. usha.nagaraj@cchmc.org. 2. Pediatric Surgery (J.L.P.) University of Cincinnati College of Medicine (U.D.N., J.L.P., K.S.B., B.M.K.-F), Cincinnati, Ohio. 3. Pediatric Neurosurgery (K.S.B.), Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio University of Cincinnati College of Medicine (U.D.N., J.L.P., K.S.B., B.M.K.-F), Cincinnati, Ohio. 4. From the Departments of Radiology and Medical Imaging (U.D.N., B.M.K.-F) University of Cincinnati College of Medicine (U.D.N., J.L.P., K.S.B., B.M.K.-F), Cincinnati, Ohio.
Abstract
BACKGROUND AND PURPOSE: Subependymal grey matter heterotopias are seen in a high proportion of children with Chiari II malformation and are potentially clinically relevant. However, despite its growing use, there is little in the literature describing its detection on fetal MRI. Our aim was to evaluate the accuracy in diagnosing subependymal gray matter heterotopias in fetuses with spinal dysraphism on fetal MR imaging. MATERIALS AND METHODS: This study is a retrospective analysis of 203 fetal MRIs performed at a single institution for spinal dysraphism during a 10-year period. Corresponding obstetric sonography, postnatal imaging, and clinical/operative reports were reviewed. RESULTS: Of the fetal MRIs reviewed, 95 fetuses were included in our analysis; 23.2% (22/95) were suspected of having subependymal gray matter heterotopias on fetal MR imaging prospectively. However, only 50% (11/22) of these cases were confirmed on postnatal brain MR imaging. On postnatal brain MR imaging, 28.4% (27/95) demonstrated imaging findings consistent with subependymal gray matter heterotopia. Only 40.7% (11/27) of these cases were prospectively diagnosed on fetal MR imaging. CONCLUSIONS: Fetal MR imaging is limited in its ability to identify subependymal gray matter heterotopias in fetuses with spinal dysraphism. It is believed that this limitation relates to a combination of factors, including artifacts from fetal motion, the very small size of fetal neuroanatomy, differences in imaging techniques, and, possibly, irregularity related to denudation of the ependyma/subependyma in the presence of spinal dysraphism and/or stretching of the germinal matrix in ventriculomegaly.
BACKGROUND AND PURPOSE:Subependymal grey matter heterotopias are seen in a high proportion of children with Chiari II malformation and are potentially clinically relevant. However, despite its growing use, there is little in the literature describing its detection on fetal MRI. Our aim was to evaluate the accuracy in diagnosing subependymal gray matter heterotopias in fetuses with spinal dysraphism on fetal MR imaging. MATERIALS AND METHODS: This study is a retrospective analysis of 203 fetal MRIs performed at a single institution for spinal dysraphism during a 10-year period. Corresponding obstetric sonography, postnatal imaging, and clinical/operative reports were reviewed. RESULTS: Of the fetal MRIs reviewed, 95 fetuses were included in our analysis; 23.2% (22/95) were suspected of having subependymal gray matter heterotopias on fetal MR imaging prospectively. However, only 50% (11/22) of these cases were confirmed on postnatal brain MR imaging. On postnatal brain MR imaging, 28.4% (27/95) demonstrated imaging findings consistent with subependymal gray matter heterotopia. Only 40.7% (11/27) of these cases were prospectively diagnosed on fetal MR imaging. CONCLUSIONS: Fetal MR imaging is limited in its ability to identify subependymal gray matter heterotopias in fetuses with spinal dysraphism. It is believed that this limitation relates to a combination of factors, including artifacts from fetal motion, the very small size of fetal neuroanatomy, differences in imaging techniques, and, possibly, irregularity related to denudation of the ependyma/subependyma in the presence of spinal dysraphism and/or stretching of the germinal matrix in ventriculomegaly.
Authors: M Aertsen; J Verduyckt; F De Keyzer; T Vercauteren; F Van Calenbergh; L De Catte; S Dymarkowski; P Demaerel; J Deprest Journal: AJNR Am J Neuroradiol Date: 2018-12-27 Impact factor: 3.825
Authors: R A Didier; J S Martin-Saavedra; E R Oliver; S E DeBari; L T Bilaniuk; L J Howell; J S Moldenhauer; N S Adzick; G G Heuer; B G Coleman Journal: AJNR Am J Neuroradiol Date: 2020-09-17 Impact factor: 3.825
Authors: Nada Mufti; Adalina Sacco; Michael Aertsen; Fred Ushakov; Sebastian Ourselin; Dominic Thomson; Jan Deprest; Andrew Melbourne; Anna L David Journal: Neuroradiology Date: 2021-11-18 Impact factor: 2.804
Authors: Nada Mufti; Michael Aertsen; Michael Ebner; Lucas Fidon; Premal Patel; Muhamad Bin Abdul Rahman; Yannick Brackenier; Gregor Ekart; Virginia Fernandez; Tom Vercauteren; Sebastien Ourselin; Dominic Thomson; Luc De Catte; Philippe Demaerel; Jan Deprest; Anna L David; Andrew Melbourne Journal: Neuroradiology Date: 2021-05-01 Impact factor: 2.995